PharmaCyte Biotech, Inc. — SC 13G/A Filings
7 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by PharmaCyte Biotech, Inc. (PMCB), sorted by most recent first. Each row links to the full filing on EdgarLookup. PharmaCyte Biotech, Inc. has filed 7 SC 13G/A documents with the SEC since 2001. To view all SEC filings by PharmaCyte Biotech, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10QSB/A
3
4
424B2
424B3
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DFAN14A
EFFECT
NT 10-K
NT 10-Q
NTN 10K
NTN 10Q
PRE 14A
PREC14A
S-3
S-3/A
S-3MEF
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-24-097260 | Nov 13, 2024 | — |
| SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | 0001213900-24-010294 | Feb 6, 2024 | — |
| SC 13G/A | — | 0001193805-23-000217 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-23-009110 | Feb 8, 2023 | — |
| SC 13G/A | SABBY 13GA PMCB 1.10.23 | 0001535610-23-000018 | Jan 10, 2023 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-22-006702 | Feb 11, 2022 | — |
| SC 13G/A | SABBY 13G-A PMCB 1.04.22 | 0001535610-22-000026 | Jan 4, 2022 | — |